Stay updated on GSK2857916 Dose Escalation Clinical Trial

Sign up to get notified when there's something new on the GSK2857916 Dose Escalation Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GSK2857916 Dose Escalation Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    Added related topic links for Multiple Myeloma and MedlinePlus Genetics on the page.
    Difference
    0.1%
    Check dated 2025-12-30T18:51:24.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The Locations section has been expanded to include multiple sites in the US and Canada (Massachusetts, New York, North Carolina, Pennsylvania, Texas, Washington, British Columbia, Ontario). The page revision is updated to v3.3.3.
    Difference
    0.7%
    Check dated 2025-12-23T17:27:04.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    Core content removed: the study's condition 'Multiple Myeloma' and the related topic 'MedlinePlus Genetics' are no longer displayed on the page.
    Difference
    0.1%
    Check dated 2025-12-09T00:58:32.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Publications section now states that PubMed publications are automatically filled from PubMed, and the page revision is updated from v3.2.0 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-24T20:54:28.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    Removed the government funding status notice from the page; the study details and other information remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-17T18:13:10.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    The new screenshot mirrors the prior version, with only minor layout adjustments and no changes to core study details such as title, conditions, interventions, primary outcomes, eligibility, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T13:05:42.000Z thumbnail image

Stay in the know with updates to GSK2857916 Dose Escalation Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GSK2857916 Dose Escalation Clinical Trial page.